Personalized Treatment in the Management of Comorbidities
Dr. Cooper reviews the relationship be comorbidities, disease, and personalized treatments.
Wednesday, January 25, 2023
Resource Tag: Think Tank
Efficacy of Biologics in Terms of True Disease Modification
Dr. Gordon discusses how medication can be used to conceptualize and modify psoriasis.
Wednesday, January 25, 2023
What is Disease Memory in Psoriasis?
Dr. Gudjonsson highlights disease memory and how it can provide a potential treatment target.
Wednesday, January 25, 2023
How to KNOCK OUT Disease Memory
Dr. Blauvelt discusses results from his research study where high doses of a medication is provided to “knock out” disease
Wednesday, January 25, 2023
Biomarkers in the Long-term Management of Psoriasis
Dr. Smith reviews how biomarkers can be used to identify patients at risk for severe disease and those who would
Wednesday, January 25, 2023
Focus on Psoriasis: A Report from the 2022 IPC Think Tank – Miami
Under the title, What’s Next in Psoriasis? From Maintenance to Disease Modification, the 2022 IPC Think Tank scientific symposium was
Tuesday, January 24, 2023
Skin of Color and Psoriasis
Dr. Alexis discusses how skin of color relates to variations in epidemiology, the clinical presentation, and overall impact psoriasis can
Monday, January 23, 2023
